Enlivex Therapeutics (ENLV) Institutional Ownership $0.86 +0.01 (+0.58%) Closing price 04/17/2025 03:55 PM EasternExtended Trading$0.86 0.00 (0.00%) As of 04/17/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Enlivex Therapeutics (NASDAQ:ENLV)CurrentInstitutional OwnershipPercentage1.02%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$3.37MNumber ofInstitutional Sellers(last 12 months)0 Get ENLV Insider Trade Alerts Want to know when executives and insiders are buying or selling Enlivex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ENLV Institutional Buying and Selling by Quarter Enlivex Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Millennium Management LLC633,847$742K0.0%N/A2.961% 2/14/2025Two Sigma Securities LLC22,362$26K0.0%N/A0.104% 2/13/2025Renaissance Technologies LLC158,992$186K0.0%+112.6%0.743% 10/23/2024Sigma Investment Counselors Inc.30,000$50K0.0%N/A0.140% 8/15/2024Armistice Capital LLC1,700,571$2.42M0.0%N/A8.148% 8/12/2024XTX Topco Ltd24,820$35K0.0%N/A0.119% 5/1/2023 Compagnie Lombard Odier SCmA65,000$225K0.0%+30.0%0.350% 2/9/2023Group One Trading L.P.13,499$53K0.0%+2,689.0%0.073% 7/11/2022ARK Investment Management LLC331,001$1.66M0.0%-23.8%1.802% 4/27/2022 Compagnie Lombard Odier SCmA50,000$279K0.0%+16.3%0.273% Get the Latest News and Ratings for ENLV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/20/2022Belvedere Trading LLC14,473$101K0.0%-13.9%0.079% 4/19/2022ARK Investment Management LLC434,343$2.43M0.0%+24.3%2.372% 2/9/2022 Compagnie Lombard Odier SCmA43,000$247K0.0%+22.9%0.235% 2/3/2022ACT Capital Management LLC25,000$156K0.1%-69.7%0.137% 1/28/2022ARK Investment Management LLC349,308$2.18M0.0%-23.7%1.908% 1/21/2022Golden Green Inc.19,967$125K0.1%-54.7%0.109% 11/12/2021Renaissance Technologies LLC87,989$869K0.0%-55.0%0.481% 10/28/2021 Compagnie Lombard Odier SCmA35,000$353K0.0%+40.0%0.191% 10/8/2021Golden Green Inc.44,085$436K0.3%-4.2%0.241% 8/13/2021Renaissance Technologies LLC195,706$1.74M0.0%-32.6%1.242% 8/11/2021Banque Cantonale Vaudoise10,000$89K0.0%N/A0.063% 8/5/2021ARK Investment Management LLC514,807$4.58M0.0%+8.1%3.267% 7/17/2021Golden Green Inc.46,020$410K0.3%-34.1%0.292% 5/18/2021Jane Street Group LLC11,070$123K0.0%N/A0.070% 5/17/2021Edmond DE Rothschild Holding S.A.13,000$144K0.0%N/A0.082% 5/17/2021Goldman Sachs Group Inc.12,986$144K0.0%N/A0.082% 5/13/2021ARK Investment Management LLC476,414$5.28M0.0%N/A3.023% 5/13/2021Renaissance Technologies LLC290,406$3.22M0.0%+4.0%1.843% 5/12/2021UBS Group AG10,872$120K0.0%-51.5%0.069% 4/23/2021 Compagnie Lombard Odier SCmA25,000$267K0.0%N/A0.159% (Data available from 1/1/2016 forward) ENLV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ENLV shares? During the previous two years, the following institutional investors and hedge funds held shares of Enlivex Therapeutics shares: Armistice Capital LLC ($2.42M), Millennium Management LLC ($742K), Compagnie Lombard Odier SCmA ($225K), Renaissance Technologies LLC ($186K), Sigma Investment Counselors Inc. ($50K), and XTX Topco Ltd ($35K), and Two Sigma Securities LLC ($26K).Learn more on ENLV's institutional investors. What percentage of Enlivex Therapeutics stock is owned by institutional investors? 1.02% of Enlivex Therapeutics stock is owned by institutional investors. Learn more on ENLV's institutional investor holdings. Which institutional investors have been buying Enlivex Therapeutics stock? The following institutional investors have purchased Enlivex Therapeutics stock in the last 24 months: Armistice Capital LLC ($1.70M), Millennium Management LLC ($633.85K), Renaissance Technologies LLC ($84.20K), Sigma Investment Counselors Inc. ($30K), XTX Topco Ltd ($24.82K), Two Sigma Securities LLC ($22.36K), and Compagnie Lombard Odier SCmA ($15K). How much institutional buying is happening at Enlivex Therapeutics? Institutional investors have bought a total of 2,510,803 shares in the last 24 months. This purchase volume represents approximately $3.42M in transactions. Related Companies CRBU Institutional Ownership XCUR Institutional Ownership EPIX Institutional Ownership UNCY Institutional Ownership SGMT Institutional Ownership ADAG Institutional Ownership ADVM Institutional Ownership IGMS Institutional Ownership LXEO Institutional Ownership CRBP Institutional Ownership This page (NASDAQ:ENLV) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enlivex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENLV Stock Free ENLV Stock Alerts